FUNDAMENTALS · Fundamentals · CN Healthcare

Ping An Healthcare and Technology (1833) Fundamentals 2026 — P/E 36.7x, Revenue Analysis | SniperIQ

Ping An Healthcare and Technology (1833) is a CN-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of HK

6.1B, trading at HK$7.55 on the HKSE. This SniperIQ fundamentals page covers Ping An Healthcare and Technology's valuation (P/E 36.7x, P/B 1.5x), profitability (net margin 6.9%), revenue (¥5.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
6.1B
P/E (TTM)36.7x
Net Margin6.9%
Revenue (FY25)¥5.5B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Ping An Healthcare and Technology's market cap?

Ping An Healthcare and Technology (1833) has a market capitalization of approximately HK

6.1B, trading at HK$7.55 on the HKSE. Market cap moves with the live share price.

What is Ping An Healthcare and Technology's P/E ratio?

Ping An Healthcare and Technology's trailing twelve-month P/E ratio is 36.7x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Ping An Healthcare and Technology?

Ping An Healthcare and Technology runs a net profit margin of 6.9%, a gross margin of 32.4%, and an operating margin of 1.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Ping An Healthcare and Technology generate?

Ping An Healthcare and Technology reported revenue of ¥5.5B for fiscal year 2025, with net income of ¥380M and earnings per share (EPS) of 0.18. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Ping An Healthcare and Technology pay a dividend?

Ping An Healthcare and Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Ping An Healthcare and Technology financially healthy?

Ping An Healthcare and Technology carries a debt-to-equity ratio of 0.00x and a current ratio of 2.70x, with a market beta of 1.11. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Ping An Healthcare and Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ping An Healthcare and Technology (1833) the key facts are: market cap HK

6.1B, P/E 36.7x, revenue ¥5.5B, 52-week range 6.57-24.4. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Ping An Healthcare and Technology's full fundamentals live

Get Ping An Healthcare and Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Tonghua Dongbao Pharmaceutical (600867) fundamentals · China Resources Jiangzhong Pharmaceutical (600750) fundamentals · BridgeBio Pharma (BBIO) fundamentals · Topchoice Medical (600763) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons